Additional file 2 of Impact of the SARS-CoV-2 nucleocapsid 203K/204R mutations on the inflammatory immune response in COVID-19 severity

Additional file 2: Table S1. Demorgraphic and clinical information of all samples. Table S2. All significant DE genes (KR-patients versus Healthy). Table S3. All significant DE genes (RG-patients versus Healthy). Table S4. All DE genes (KR-patients versus RG-patients ). Table S5. Transcriptome Pathways enrichment (biological processes). Table S6. Significant DE genes KR-VLP versus control. Table S7. Significant DE genes D614G-VLP versus control. Table S8. Significant DE genes D614G-KR-VLP versus control. Table S9. Significant DE genes WT-VLP versus control. Table S10. Pathways enrichment (biological processes). Table S11. All DE proteins in KR, D614G-KR, and D614G versus WT. Table S12. Proteome Pathways enrichment (biological processes).